Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in Pichia pastoris.

Applied Microbiology and Biotechnology
Byung-Kwon ChoiNatarajan Sethuraman

Abstract

Yeast is capable of performing posttranslational modifications, such as N- or O-glycosylation. It has been demonstrated that N-glycans play critical biological roles in therapeutic glycoproteins by modulating pharmacokinetics and pharmacodynamics. However, N-glycan sites on recombinant glycoproteins produced in yeast can be underglycosylated, and hence, not completely occupied. Genomic homology analysis indicates that the Pichia pastoris oligosaccharyltransferase (OST) complex consists of multiple subunits, including OST1, OST2, OST3, OST4, OST5, OST6, STT3, SWP1, and WBP1. Monoclonal antibodies produced in P. pastoris show that N-glycan site occupancy ranges from 75-85 % and is affected mainly by the OST function, and in part, by process conditions. In this study, we demonstrate that N-glycan site occupancy of antibodies can be improved to greater than 99 %, comparable to that of antibodies produced in mammalian cells (CHO), by overexpressing Leishmania major STT3D (LmSTT3D) under the control of an inducible alcohol oxidase 1 (AOX1) promoter. N-glycan site occupancy of non-antibody glycoproteins such as recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) was also significantly improved, suggesting tha...Continue Reading

References

Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A H HorwitzR R Robinson
Jun 24, 1987·Biochimica Et Biophysica Acta·H A KaplanW J Lennarz
Jan 21, 2000·FEMS Microbiology Reviews·J L Cereghino, J M Cregg
Apr 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Byung-Kwon ChoiTillman U Gerngross
May 21, 2003·The Journal of Cell Biology·IngMarie NilssonArthur E Johnson
Jun 26, 2003·Nucleic Acids Research·Ramu ChennaJulie D Thompson
Jun 26, 2003·Protein Science : a Publication of the Protein Society·Jing Liu, Arcady Mushegian
Aug 30, 2003·Science·Stephen R HamiltonTillman U Gerngross
Sep 30, 2003·Glycobiology·Shifra Ben-DorNathan Sharon
May 7, 2004·Applied and Environmental Microbiology·Michael WardHuaming Wang
Jun 17, 2005·Journal of Pharmaceutical Sciences·Angus M Sinclair, Steve Elliott
Aug 30, 2005·Biochimica Et Biophysica Acta·Jullian JonesMichael J Betenbaugh
Jan 24, 2006·Nature Biotechnology·Huijuan LiTillman U Gerngross
Sep 9, 2006·Science·Stephen R HamiltonTillman U Gerngross
Oct 24, 2007·Current Opinion in Biotechnology·Stephen R Hamilton, Tillman U Gerngross
Jan 10, 2009·Nature Protocols·Pieter P JacobsNico Callewaert
Jan 24, 2009·Journal of Biotechnology·Thomas I PotgieterMarc d'Anjou
Jun 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Benjamin L SchulzMarkus Aebi
Sep 22, 2009·Methods in Molecular Biology·Theresa C SwayneLiza A Pon
Dec 17, 2009·The Journal of Biological Chemistry·Nobuo MaitaDaisuke Kohda
Aug 17, 2010·Journal of Industrial Microbiology & Biotechnology·Gavin C BarnardPiotr Bobrowicz

❮ Previous
Next ❯

Citations

Sep 3, 2013·Applied Biochemistry and Biotechnology·Renata DamianiMaria Teresa C P Ribela
Dec 4, 2012·Applied and Environmental Microbiology·Farnoush Parsaie NasabAlexander Daniel Frey
Feb 15, 2014·Applied Microbiology and Biotechnology·Sujatha Gomathinayagam, Stephen R Hamilton
Feb 15, 2014·Applied Microbiology and Biotechnology·Daniel HopkinsStephen R Hamilton
Jul 16, 2015·Expert Opinion on Biological Therapy·Martina Dicker, Richard Strasser
Sep 5, 2015·Current Opinion in Biotechnology·Diana Chinyere Anyaogu, Uffe Hasbro Mortensen
Mar 15, 2016·Applied Biochemistry and Biotechnology·Weiwei ChenLidan Ye
Nov 11, 2014·Applied Microbiology and Biotechnology·Daniel HopkinsStephen R Hamilton
Feb 28, 2015·Applied Microbiology and Biotechnology·Verena PuxbaumBrigitte Gasser
Jan 20, 2015·Future Microbiology·Bram LaukensNico Callewaert
Nov 12, 2016·World Journal of Microbiology & Biotechnology·Amjad Hayat KhanAzam Rahimpour
Jul 12, 2014·Current Opinion in Biotechnology·Michael A Meehl, Terrance A Stadheim
Sep 21, 2017·The Journal of Biological Chemistry·Anders JinnelovMichael A J Ferguson
Sep 10, 2014·Biotechnology Progress·Muralidhar MallemByung-Kwon Choi
Aug 5, 2020·Molecular Biotechnology·Amjad Hayat KhanRahmah Noordin
Dec 8, 2015·Glycoconjugate Journal·Lucia F Zacchi, Benjamin L Schulz
Oct 17, 2017·Molecular Immunology·Ishan S ShahThomas J Tolbert
Jun 12, 2020·ACS Synthetic Biology·Weston KightlingerMichael C Jewett
Mar 19, 2014·New Biotechnology·Mari A PiirainenAlexander D Frey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.